| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.598 | 11.507 | 17.704 | 12.000 | 15.211 | 12.032 | 7.582 | 8.427 | 11.090 | 8.195 |
| Total Income - EUR | 15.454 | 11.507 | 18.454 | 12.000 | 15.211 | 12.032 | 7.582 | 8.460 | 11.140 | 8.264 |
| Total Expenses - EUR | 18.052 | 18.297 | 19.655 | 14.302 | 12.261 | 9.588 | 8.456 | 7.781 | 14.422 | 15.597 |
| Gross Profit/Loss - EUR | -2.598 | -6.790 | -1.201 | -2.302 | 2.950 | 2.444 | -873 | 679 | -3.282 | -7.334 |
| Net Profit/Loss - EUR | -3.006 | -6.905 | -1.378 | -2.422 | 2.798 | 2.329 | -1.101 | 481 | -3.394 | -7.416 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Lasan Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 65 | 58 | 51 | 43 | 37 | 32 | 23 | 24 | 12 | 6 |
| Current Assets | 3.605 | 3.655 | 5.177 | 2.976 | 4.077 | 5.652 | 3.942 | 5.480 | 13.273 | 23.739 |
| Inventories | 2.038 | 2.408 | 3.388 | 1.821 | 1.824 | 3.317 | 1.708 | 1.226 | 7.161 | 20.644 |
| Receivables | 996 | 1.033 | 910 | 756 | 545 | 561 | 624 | 636 | 817 | 1.193 |
| Cash | 571 | 214 | 879 | 398 | 1.708 | 1.773 | 1.609 | 3.618 | 5.295 | 1.902 |
| Shareholders Funds | -11.780 | -18.565 | -19.628 | -21.690 | -18.473 | -15.793 | -16.544 | -16.115 | -19.459 | -26.767 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.385 | 22.278 | 24.793 | 24.648 | 22.526 | 21.418 | 20.451 | 21.560 | 32.686 | 50.512 |
| Income in Advance | 64 | 63 | 62 | 61 | 60 | 59 | 58 | 58 | 58 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5811 - 5811" | |||||||||
| CAEN Financial Year |
5811
|
|||||||||
Comments - Lasan Med S.r.l.